MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2

The mitotic arrest deficient protein mad2b is a well-defined anaphase-promoting complex/cyclosome (apc/c) inhibitor and a small subunit of dna polymerase zeta. it is critical for mitotic control and dna repair. however, the pathological role of mad2b in kidney diseases has not been fully elucidated. in the present study, we aim to explore the role of mad2b in the pathogenesis of renal tubulointerstitial fibrosis (tif) and the underlying mechanism. by immunofluorescence and immunohistochemistry, we found an obvious mad2b enhancement in tubular area of tif patients and unilateral ureteral obstruction (uuo) mice. in vitro, transforming growth factor-β1 (tgf-β1) induced a time-dependent mad2b accumulation prior to tubular epithelial-to-mesenchymal transition (emt) in a rat proximal tubular epithelial cell line, nrk-52e. knocking down mad2b using sirna dramatically inhibited tgf-β1-induced tubular emt process and subsequent extracellular matrix (ecm) production. we also found that skp2, a confirmed apc/c-cdh1 substrate and e-cadherin destroyer, was increased in tgf-β1-treated proximal tubular epithelial cells, which could be blocked by mad2b depletion. in addition, skp2 expression was also found to be increased in the renal tubular area of uuo mice. locally knocking down mad2b expression in the renal cortex using lentiviral transfection inhibited skp2 expression, tubular emt, and subsequent ecm accumulation. taken together, our data suggests a pro-fibrotic role of mad2b in the pathogenesis of tubular emt and tif by inducing skp2 expression. mad2b might be a potential target of promising interventions for renal tif.